Table 2.
Reclassification of liver transplant candidates between MELDNa and MELD3.0 in the validation set. (A) the number of patients, (B) the number of deaths and (C) the proportion of death (B divided by A). Red-demarcated areas indicate up-scoring (MELD3.0 category higher than MELDNa) and blue-demarcated areas the opposite.
A. Patients (n) | MELD 3.0 | |||||
---|---|---|---|---|---|---|
6–9 | 10–19 | 20–29 | 30–39 | 40+ | ||
MELDNa | 6–9 | 1047 | 334 | - | - | - |
10–19 | 66 | 3093 | 341 | - | - | |
20–29 | - | 150 | 2182 | 140 | - | |
30–39 | - | - | 64 | 1007 | 75 | |
40+ | - | - | - | 26 | 298 | |
B. Deaths (n) | MELD 3.0 | |||||
6–9 | 10–19 | 20–29 | 30–39 | 40+ | ||
MELDNa | 6–9 | 6 | 4 | - | - | - |
10–19 | - | 45 | 16 | - | - | |
20–29 | - | 6 | 166 | 23 | - | |
30–39 | - | - | 8 | 141 | 19 | |
40+ | - | - | - | 3 | 77 | |
C. Death (%) | MELD 3.0 | |||||
6–9 | 10–19 | 20–29 | 30–39 | 40+ | ||
MELDNa | 6–9 | 0.6% | 1.2% | - | - | - |
10–19 | - | 1.5% | 4.7% | - | - | |
20–29 | - | 4.0% | 7.6% | 16.4% | - | |
30–39 | - | - | 12.5% | 14.0% | 25.3% | |
40+ | - | - | - | 11.5% | 25.8% |